Literature DB >> 31650987

Surveillance of laboratory exposures to human pathogens and toxins: Canada 2018.

D Choucrallah1, L Sarmiento1, S Ettles1, F Tanguay1, M Heisz1, E Falardeau1.   

Abstract

BACKGROUND: The Laboratory Incident Notification Canada (LINC) surveillance system monitors laboratory incidents reported under the Human Pathogens and Toxins Act. The year 2018 marks the third complete year of data.
OBJECTIVE: To describe the laboratory exposure and laboratory-acquired infection incidents that occurred in Canada in 2018 compared to previous years, and then by sector, human pathogens and toxins involved, number of affected persons, incident type and root causes.
METHODS: Laboratory incidents that occurred in 2018 were reported through the LINC system. The number of laboratory incidents, people exposed and laboratory-acquired infections were compared to previous years, then the incidents were analyzed by sector, human pathogen or toxin involved, the type of incident, people exposed, route of exposure and root causes. Microsoft Excel 2016 was used for descriptive analysis.
RESULTS: In 2018, there were 89 exposure incidents to human pathogens and 235 people were exposed. There were five suspected and one confirmed laboratory-acquired infections. This was approximately twice the number of exposure incidents that were reported in 2017 (n=44) and 2016 (n=46). The highest number of exposure incidents occurred in the academic and hospital sectors, and the ratio of incidence to licences was the lowest in the private sector. The majority of incidents (n=50; 56%) involved Risk Group 2 human pathogens that were manipulated in a Containment Level 2 laboratory. Most exposures were related to sharps or procedures and the most common people exposed were laboratory technicians. Human interaction and standard operating procedures were the leading root causes.
CONCLUSION: Although overall the annual incidence of laboratory exposures in Canada remains relatively low, the incidence was higher in 2018 than in previous years. Whether this is a true increase in incidence or an increase in reporting is not known at this time as baseline estimates are still being established.

Entities:  

Keywords:  Centre for Biosecurity; Laboratory Incident Notification Canada; human pathogens and toxins; laboratory exposures; laboratory incidents; laboratory-acquired infections; surveillance

Year:  2019        PMID: 31650987      PMCID: PMC6781952          DOI: 10.14745/ccdr.v45i09a04

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  9 in total

1.  Bacterial and fungal infections among diagnostic laboratory workers: evaluating the risks.

Authors:  Ellen Jo Baron; J Michael Miller
Journal:  Diagn Microbiol Infect Dis       Date:  2007-11-08       Impact factor: 2.803

Review 2.  Laboratory-associated infections: incidence, fatalities, causes, and prevention.

Authors:  R M Pike
Journal:  Annu Rev Microbiol       Date:  1979       Impact factor: 15.500

Review 3.  A literature review of laboratory-acquired brucellosis.

Authors:  Rita M Traxler; Mark W Lehman; Elizabeth A Bosserman; Marta A Guerra; Theresa L Smith
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

4.  Research funding. A framework for decisions about research with HPAI H5N1 viruses.

Authors:  Amy P Patterson; Lawrence A Tabak; Anthony S Fauci; Francis S Collins; Sally Howard
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

Review 5.  Laboratory-associated infections and biosafety.

Authors:  D L Sewell
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017.

Authors:  D Pomerleau-Normandin; M Heisz; F Tanguay
Journal:  Can Commun Dis Rep       Date:  2018-11-01

Review 7.  Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

Authors:  Ana Cláudia Coelho; Juan García Díez
Journal:  Front Bioeng Biotechnol       Date:  2015-04-28

Review 8.  A Review of Laboratory-Acquired Infections in the Asia-Pacific: Understanding Risk and the Need for Improved Biosafety for Veterinary and Zoonotic Diseases.

Authors:  Jarunee Siengsanan-Lamont; Stuart D Blacksell
Journal:  Trop Med Infect Dis       Date:  2018-03-26

9.  Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.

Authors:  A Bienek; M Heisz; M Su
Journal:  Can Commun Dis Rep       Date:  2017-11-02
  9 in total
  2 in total

1.  Surveillance of laboratory exposures to human pathogens and toxins, Canada 2020.

Authors:  Nicole Atchessi; Megan Striha; Rojiemiahd Edjoc; Emily Thompson; Maryem El Jaouhari; Marianne Heisz
Journal:  Can Commun Dis Rep       Date:  2021-10-14

Review 2.  Zika Virus Infection During Research Vaccine Development: Investigation of the Laboratory-Acquired Infection via Nanopore Whole-Genome Sequencing.

Authors:  Eunsik Bang; Sujin Oh; Ho Eun Chang; Il Seob Shin; Kyoung Un Park; Eu Suk Kim
Journal:  Front Cell Infect Microbiol       Date:  2022-03-07       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.